News Conference News AHA 2025 LAAO Doesn’t Match Medical Therapy for High-risk AF Patients: CLOSURE-AF Caitlin E. Cox November 09, 2025
News Conference News AHA 2022 BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI Shelley Wood November 06, 2022
News Conference News AHA 2022 Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link L.A. McKeown November 01, 2022
News Conference News AHA 2021 Empagliflozin Retains Benefits in ‘True’ HFpEF Patients Todd Neale November 17, 2021
News Conference News AHA 2021 RAPID CABG: No Penalty to Early Surgery for ACS After Stopping Ticagrelor Yael L. Maxwell November 13, 2021
News Conference News AHA 2021 Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years Caitlin E. Cox November 13, 2021
News Conference News AHA 2020 FIDELIO-DKD: Finerenone Cuts CV Events in Diabetic Kidney Disease Todd Neale November 16, 2020
News Conference News AHA 2020 Fish Oil, Vitamin D Don’t Prevent A-fib: VITAL Rhythm Todd Neale November 13, 2020
News Conference News AHA 2019 TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences Yael L. Maxwell November 18, 2019
News Conference News AHA 2018 New-Generation DES Better Than Older Stents Over 10 Years, Regardless of Polymer Type Todd Neale November 12, 2018
News Conference News AHA 2018 Long-term IABP-SHOCK II Data Offer Rare Look at Poor Prognosis in Acute MI Cardiogenic Shock Patients Caitlin E. Cox November 11, 2018
News Conference News AHA 2017 ‘Acceptable Safety’ for LAA Closure Seen in a Real-World, All-Comers Registry Todd Neale November 22, 2017
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Conference News AHA 2016 Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients Michael O'Riordan November 16, 2016
News Conference News AHA 2016 Stark Mortality Differences Seen in GARY Registry Tracking TAVR and Surgical Replacement Shelley Wood November 14, 2016
News Conference News AHA 2014 ISAR-SAFE: Another Randomized Trial Finds 6 Months of DAPT as Good as 12 Months November 15, 2014
News Conference News Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk November 17, 2011
News Conference News Study Looks at Surgery vs. Transcatheter Treatment for Aortic Stenosis Plus CAD November 15, 2011
News Conference News ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients November 13, 2011